Bitter Melon (Momordica charantia)

Momordica charantia
Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Bitter melon (also called bitter gourd, karela) is a tropical vine fruit used as both food and medicine across South Asia, Africa, and the Caribbean. It has a long tradition of use for blood sugar in those regions. Active compounds include charantin, vicine, polypeptide-p ('plant insulin'), and momordicin. The human research cited here was done entirely in people already diagnosed with prediabetes or type 2 diabetes, where it produced small improvements in blood sugar markers. It is not a diabetes treatment and must not replace prescribed medication. Critical caution: contains potential teratogens — avoid during pregnancy. Vicine in the seeds can trigger favism, a form of hemolytic anemia, in people with G6PD deficiency. Concentrated forms can also lower blood sugar, which matters for anyone taking insulin or other glucose-lowering medication.

Studied Dose 1–3 g/day fruit/seed powder; 200–500 mg/day standardized extract; juice 50–100 mL/day. These amounts come from studies in people with prediabetes or type 2 diabetes. In the 4-week trial that compared bitter melon with metformin, only the highest dose tested, 2,000 mg a day, moved a blood sugar marker at all. No dose has been established for people without a blood sugar problem.
Active Compound Charantin (cucurbitane-type triterpenoids), polypeptide-p ('plant insulin'), vicine, momordicin.

Benefits

T2DM Glycemic Modest Improvement

Two meta-analyses of randomised trials, published in 2024 and 2025, found bitter melon supplementation produced modest improvements in blood sugar control in people with prediabetes or type 2 diabetes. Everyone studied already had a diagnosis, so this says nothing about people with normal blood sugar. In a 4-week trial that compared it head to head with metformin, the effect was smaller than the drug's, and results vary widely by formulation, dose and study length.

Insulin Secretion, Studied in Type 2 Diabetes

Polypeptide-p is a compound in bitter melon that resembles insulin in structure, which is why older writing called it 'plant insulin'. That resemblance comes from laboratory work, not from tests in people. The only human study cited here for this is a 2018 trial in patients with type 2 diabetes, which reported improved insulin secretion in that group.

Antioxidant Activity in Lab Studies Only

Several bitter melon compounds show antioxidant and anti-inflammatory activity in laboratory dish experiments. None of the studies cited on this page measured inflammation or antioxidant markers in people, so there is no human evidence behind this and no basis for saying it contributes to any metabolic effect.

Cholesterol Modest Reduction

A 2024 systematic review and meta-analysis reported modest improvements in blood fats alongside blood sugar in people with type 2 diabetes. These results are less consistent than the blood sugar findings and, like them, come only from people who already had a diabetes diagnosis.

Weight: Not Measured in the Cited Studies

None of the studies cited on this page measured body weight, body fat or waist size, so there is nothing here to support using bitter melon for weight management.

Mechanism of action

1

Insulin Receptor Activation

In laboratory and animal experiments, polypeptide-p and other bitter melon compounds act on insulin receptor signalling in a way that partly mimics insulin. This has not been shown directly in people.

2

AMPK Activation

Cell and animal studies show bitter melon compounds switch on an energy-sensing enzyme called AMPK, which is also activated by exercise. In those models this increases glucose uptake and reduces glucose production by the liver. These are preclinical findings, and bitter melon is not a substitute for any medication.

3

Alpha-Glucosidase Inhibition

In test-tube studies, bitter melon compounds slow alpha-glucosidase, an enzyme that breaks down carbohydrates in the gut, which would be expected to blunt the rise in blood sugar after a meal. This is a proposed explanation from lab work, not something measured in the trials cited here.

4

Charantin Triterpenoid Effects

Charantin, a group of cucurbitane-type triterpenoids, acts on several pathways in laboratory models, including one called PPAR-gamma that is involved in insulin sensitivity. These are proposed mechanisms from preclinical work rather than effects confirmed in people.

Clinical trials

1
Bitter Melon for T2DM

Clinical trial comparing bitter melon (500 mg or 1,000 mg or 2,000 mg/day) vs metformin (1,000 mg/day) in 143 T2DM patients for 4 weeks.

143 T2DM patients.

Only the highest dose, 2,000 mg a day, produced a small drop in fructosamine, a short-term blood sugar marker, and that drop was smaller than metformin's. The 500 mg and 1,000 mg doses had little effect. Important limits: the trial ran only 4 weeks, everyone enrolled already had diagnosed type 2 diabetes, and this trial is not among the references listed on this page.

2
Bitter Melon Cochrane Review (Negative)

Cochrane evidence review of bitter melon for T2DM.

Pooled across T2DM clinical trials.

Insufficient evidence to recommend bitter melon for T2DM; effects modest and inconsistent across trials. Standard T2DM management primary.

Side effects and drug interactions

Common Potential side effects

GI distress (nausea, abdominal pain, diarrhea) — particularly with juice forms.
Low blood sugar (hypoglycemia). This risk is real and adds up for anyone taking insulin, sulfonylureas, metformin or any other glucose-lowering medication. Blood sugar should be monitored and any use discussed with the prescribing clinician.
Favism in people with G6PD deficiency. Bitter melon seeds contain vicine (same compound as fava beans) that causes hemolytic anemia in G6PD-deficient people; avoid seeds in this population.
Headache.
Bitter taste — major palatability issue with juice/whole fruit.
Avoid in pregnancy. Bitter melon is traditionally used to bring on menstruation and to end pregnancy, and animal studies point to harm to the developing fetus.
Liver enzyme elevation (rare).

Important Drug interactions

Insulin / sulfonylureas — additive hypoglycemic; monitor closely.
Metformin. Taking both can lower blood sugar more than either alone. Monitor blood sugar and speak to your doctor before adding it.
GLP-1 agonists and SGLT2 inhibitors. Blood sugar may fall further than expected, so monitor closely and check with your prescriber.
Anticoagulants — theoretical bleeding risk at high doses.
Drugs metabolized by CYP enzymes — bitter melon may modestly affect; theoretical interactions.

Frequently asked questions about Bitter Melon (Momordica charantia)

What is bitter melon used for?

Bitter melon is a tropical vegetable used, especially in Asian traditions, for blood-sugar support. It is eaten as a food or taken as juice or a standardized extract. The clinical studies behind that use were all carried out in people with prediabetes or type 2 diabetes, and bitter melon is not a treatment for either condition.

Does bitter melon help with blood sugar?

The trials and meta-analyses cited here found small improvements in blood sugar markers, but every one of them enrolled people already diagnosed with prediabetes or type 2 diabetes. In a 4-week head to head trial the effect was smaller than metformin's, and a Cochrane review concluded the evidence was not strong enough to recommend it. There is no evidence about people with normal blood sugar, and bitter melon is not a treatment for diabetes and must not replace prescribed medication.

How much bitter melon should I take?

It is eaten as a vegetable, drunk as juice, or taken as a standardized extract; follow the product label. It is intensely bitter, hence the name. In the 4-week comparison trial, a blood sugar change only showed up at 2,000 mg a day, and the lower doses did little. There is no established amount for people who do not have a diagnosed blood sugar problem, and anyone on diabetes medication should agree a dose with their doctor first.

Is bitter melon safe?

As a food it is generally well tolerated, though concentrated forms and juice commonly cause nausea, stomach pain or diarrhoea. As a supplement it can lower blood sugar, so anyone taking insulin, sulfonylureas, metformin or another glucose-lowering drug should monitor closely and speak to their doctor first. Avoid it in pregnancy: it is traditionally used to end pregnancy and animal studies suggest harm to the fetus. People with G6PD deficiency should avoid the seeds, which contain vicine and can trigger favism, a form of hemolytic anemia.

What is Bitter Melon?

Bitter melon (also called bitter gourd, karela) is a tropical vine fruit used as both food and medicine across South Asia, Africa, and the Caribbean. It has a long tradition of use for blood sugar in those regions. Active compounds include charantin, vicine, polypeptide-p ('plant insulin'), and momordicin.

What is the recommended dosage of Bitter Melon?

The clinically studied dose is 1–3 g/day fruit/seed powder; 200–500 mg/day standardized extract; juice 50–100 mL/day. These amounts come from studies in people with prediabetes or type 2 diabetes. Always follow the product label and check with a healthcare provider for personal advice.

Is Bitter Melon safe, and does it have side effects?

For most healthy adults, Bitter Melon is well tolerated at studied doses. Reported effects can include: GI distress (nausea, abdominal pain, diarrhea) — particularly with juice forms. Low blood sugar (hypoglycemia). This risk is real and adds up for anyone taking insulin, sulfonylureas, metformin or any other glucose-lowering medication. It may also interact with some medications. Bitter Melon is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Bitter Melon interact with any medications?

Possible interactions include: Insulin / sulfonylureas — additive hypoglycemic; monitor closely. Metformin. Taking both can lower blood sugar more than either alone. Monitor blood sugar and speak to your doctor before adding it. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Bitter Melon?

NutraSmarts rates the evidence for Bitter Melon as Limited (2 out of 5). It is backed by 2 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Zhang X, Zhao Y, Song Y, Miao M Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials Heliyon. 2024;10(10):e31126. doi: 10.1016/j.heliyon.2024.e31126.PubMedUsed to support: Systematic review and meta-analysis of RCTs finding Momordica charantia supplementation produced modest improvements in glycemic control and lipid profiles in T2DM patients; backs 'T2DM Glycemic Modest Improvement' and 'Cholesterol Modest Reduction'.
  2. Cortez-Navarrete M, Martínez-Abundis E, Pérez-Rubio KG, González-Ortiz M, Méndez-Del Villar M Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus Journal of Medicinal Food. 2018;21(7):672-677. doi: 10.1089/jmf.2017.0114.PubMedUsed to support: Human clinical study showing Momordica charantia administration improved insulin secretion in patients with T2DM; backs 'Insulin-Like Effects' and 'T2DM Glycemic Modest Improvement'.
  3. Mkhize SAL, Phoswa WN, Ngubane PS, Mokgalaboni K Efficacy of Momordica charantia in glycaemic control and insulin resistance among patients with prediabetes and type 2 diabetes. A GRADE-adherent meta-analysis of randomised controlled trials Metabolism Open. 2025;28:100407. doi: 10.1016/j.metop.2025.100407.PubMedUsed to support: Grade-adherent meta-analysis of RCTs assessing Momordica charantia for glycemic control and insulin resistance in prediabetes and T2DM; backs 'T2DM Glycemic Modest Improvement' and 'Insulin-Like Effects'.